Combination of HDAC inhibition and cytokine enhances therapeutic HPV vaccine therapy

Combination of HDAC inhibition and cytokine enhances therapeutic HPV vaccine therapy

Background Human papillomavirus (HPV)-associated malignancies continue to present a major health concern despite the development of prophylactic vaccines. Standard therapies offer limited benefit to patients with advanced-stage disease. Despite improved outcomes with programmed cell death protein-1...

Full description

Saved in:
Bibliographic Details
Main Authors: Jeffrey Schlom, James L Gulley, Caroline Jochems, Sofia R Gameiro, Wiem Lassoued, Daniel Burnett, Lisa K Poppe, Nicholas Roller, Miriam Marlene Medina-Enríquez, Katherine E Lothstein, Asma S Khelifa, Masaya Miyamoto
Format: Article
Language:English
Published: BMJ Publishing Group 2025-05-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/13/5/e011074.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items